Wang RF - Search Results

1

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF. Kiniwa Y, et al. Among authors: wang hy, wang rf. Clin Cancer Res. 2007 Dec 1;13(23):6947-58. doi: 10.1158/1078-0432.CCR-07-0842. Clin Cancer Res. 2007. PMID: 18056169

2

Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells.

Wang RF, Wang HY. Wang RF, et al. Among authors: wang hy. Nat Biotechnol. 2002 Feb;20(2):149-54. doi: 10.1038/nbt0202-149. Nat Biotechnol. 2002. PMID: 11821860

3

Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.

Wang HY, Zhou J, Zhu K, Riker AI, Marincola FM, Wang RF. Wang HY, et al. Among authors: wang rf. J Exp Med. 2002 Jun 3;195(11):1397-406. doi: 10.1084/jem.20020141. J Exp Med. 2002. PMID: 12045238 Free PMC article.

4

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.

Wang HY, Fu T, Wang G, Zeng G, Perry-Lalley DM, Yang JC, Restifo NP, Hwu P, Wang RF. Wang HY, et al. Among authors: wang g, wang rf. J Clin Invest. 2002 Jun;109(11):1463-70. doi: 10.1172/JCI15399. J Clin Invest. 2002. PMID: 12045260 Free PMC article.

5

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

Voo KS, Fu T, Heslop HE, Brenner MK, Rooney CM, Wang RF. Voo KS, et al. Among authors: wang rf. Cancer Res. 2002 Dec 15;62(24):7195-9. Cancer Res. 2002. PMID: 12499257

6

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF. Wang HY, et al. Among authors: wang rf. Immunity. 2004 Jan;20(1):107-18. doi: 10.1016/s1074-7613(03)00359-5. Immunity. 2004. PMID: 14738769 Free article.

7

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.

Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, Rooney CM, Wang RF. Voo KS, et al. Among authors: wang hy, wang rf. J Exp Med. 2004 Feb 16;199(4):459-70. doi: 10.1084/jem.20031219. Epub 2004 Feb 9. J Exp Med. 2004. PMID: 14769850 Free PMC article.

8

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells.

Wang HY, Peng G, Guo Z, Shevach EM, Wang RF. Wang HY, et al. Among authors: wang rf. J Immunol. 2005 Mar 1;174(5):2661-70. doi: 10.4049/jimmunol.174.5.2661. J Immunol. 2005. PMID: 15728473

9

Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation.

Voo KS, Peng G, Guo Z, Fu T, Li Y, Frappier L, Wang RF. Voo KS, et al. Among authors: wang rf. Cancer Res. 2005 Feb 15;65(4):1577-86. doi: 10.1158/0008-5472.CAN-04-2552. Cancer Res. 2005. PMID: 15735048

10

Antigen-specific CD4+ regulatory T cells in cancer: implications for immunotherapy.

Wang HY, Wang RF. Wang HY, et al. Among authors: wang rf. Microbes Infect. 2005 Jun;7(7-8):1056-62. doi: 10.1016/j.micinf.2005.03.028. Epub 2005 Apr 25. Microbes Infect. 2005. PMID: 15914063 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters